-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Osteoporosis is one of the most common bone diseases.
Osteoporosis is one of the most common bone diseases.
Results: EVS is rich in growth factors and cytokines related to bone metabolism and mesenchymal stem cell (MSC) migration
Figure 1 Characteristics of EVS isolated from human ASCs (ASC-EVS)
Figure 1 Characteristics of EVS isolated from human ASCs (ASC-EVS)
Figure 2 Administration of ASC-EVS can improve the osteoporosis phenotype of ovariectomized mice
Figure 2 Administration of ASC-EVS can improve the osteoporosis phenotype of ovariectomized mice
Figure 3 The relationship between EV cytokines and bone metabolism
Figure 3 The relationship between EV cytokines and bone metabolism
OPG, miR-21-5p and let-7b-5p in ASC-EVS can inhibit osteoclast differentiation and reduce the expression of bone resorption-related genes, suggesting that ASC-EVS is expected to be a cell-free therapeutic agent for the treatment of osteoporosis
Lee KS, Lee J, Kim HK,et al.
Extracellular vesicles from adipose tissue-derived stem cells alleviate osteoporosis through osteoprotegerin and miR-21-5p.
Leave a message here